Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: astro who wrote (786)	3/18/1998 2:43:00 PM
From: Robert van Royen	Read Replies (1) \| Respond to of 1826

To: David Cathcart While I don't have all the answers,perhaps I can shed some light on the recent market action. A week ago last Friday, the Trader for Dain Bosworth told the Trader for Schroders in New York that he possibly had a 250000 share block for sale. This has been overhanging the market,keeping the price at or around four and three quarters. Last night I got a call from a broker working for a firm called Hilliard Lyons in BattleCreek Mich.,wanting to know the MGI story. Of course, I couldn't refuse!!! This morning the same broker spoke with Charlie Mackall of AVENIR Corp., in Washington D.C. AVENIR as you probably know has filed a 13D and owns well over five percent of MGI. I am reasonbly sure Charlie spoke well of the company. BOTTOM LINE: I think the new brokerage firm is buying up the block overhanging the market. Until it is used up, I think we will see the stock stay where it is. After that, it will probably soar.......